first U.S. patients dosed in expanded Phase 1b clinical trial of CB307 for patients with mCRPC

[Maxone73]

one step at a time….immune therapy for prostate cancer is becoming hotter!

finance.yahoo.com/news/cres...

[fmenninger]

thanks for the info as it looks promising but still in early phase with a long way to go. Let’s hope it’s effective and less toxic to current immunotherapies.

Stay strong

[Maxone73 in reply to fmenninger]

There is always the clinical trial way if the results are really promising 👍🏻👍🏻